Author:
Akashi Yusaku,Kiyasu Yoshihiko,Takeuchi Yuto,Kato Daisuke,Kuwahara Miwa,Muramatsu Shino,Ueda Atsuo,Notake Shigeyuki,Nakamura Koji,Ishikawa Hiroichi,Suzuki Hiromichi
Abstract
AbstractAntigen tests for severe acute respiratory coronavirus 2 sometimes show positive lines earlier than their specified read time, although the implication of getting the results at earlier time is not well understood. This study aimed to evaluate the clinical utility of an antigen test by evaluating the time period to get positive results and by comparing the test sensitivity with that of a digital immunoassay (DIA) test.We prospectively collected additional nasopharyngeal samples from patients who had already tested positive for SARS-CoV-2 by reverse transcription PCR. The additional swab was used for an antigen test, QuickNavi™-COVID19 Ag, and the time periods to get positive results were measured. The sensitivity of QuickNavi™-COVID19 Ag was also compared with that of a DIA.In 84 of 96 (87.5%) analyzed cases, the results of QuickNavi™-COVID19 Ag were positive. The time to obtain positive results was 15.0 seconds in median (inter quartile range: 12.0-33.3, range 11-736), and was extended in samples with higher cycle thresholds (Ct) (p<0.001). Positive lines appeared within a minute in 85.7% of cases and within 5 minutes in 96.4%. The sensitivities of QuickNavi™-COVID19 Ag and the DIA were 87.5% (95% confident interval [CI]: 79.2%-93.4%) and 88.6% (95%CI: 75.4%- 96.2%), respectively. Their results were concordant in 90.9% of cases, with discrepancies present only in cases with Ct values >32.QuickNavi™-COVID19 Ag immediately showed positive results in most cases, and the time to a positive reaction may have indicated the viral load. In addition, the sensitivity of the test was comparable to the DIA.
Publisher
Cold Spring Harbor Laboratory
Reference17 articles.
1. World Health Organization. Coronavirus disease (COVID-19) Weekly Epidemiological Update and Weekly Operational Update, (2021) Accessed June 1 2021. https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situation-reports.
2. Centers for Disease Control and Prevention. Testing Strategies for SARS-CoV-2, (2021) Accessed June 1 2021. https://www.cdc.gov/coronavirus/2019-ncov/lab/resources/sars-cov2-testing-strategies.html.
3. World Health Organization. Antigen-detection in the diagnosis of SARS-CoV-2 infection using rapid immunoassays, (2020) Accessed May 23 2021. https://www.who.int/publications/i/item/antigen-detection-in-the-diagnosis-of-sars-cov-2infection-using-rapid-immunoassays.
4. Preventing COVID-19 spread in closed facilities by regular testing of employees—An efficient intervention in long-term care facilities and prisons?;PLOS ONE,2021
5. Rapid antigen screening of asymptomatic people as a public health tool to combat COVID-19
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献